Company intelligence

Deep EigenMatics

Leading the Way to AI-Driven Breakthroughs in Drug Discovery

Pharmaceutical Manufacturing

2 employees

1 public signals

Verified activity

Signals from Deep EigenMatics

1 published signal

Legal & Regulatory

Deep EigenMatics, Inc. filed for a patent titled MULTI-HEADED NEURAL NETWORKS FOR AI-BASED PROTEIN AND DRUG DESIGN with patent number US 12,725,677 B2 on September 1st, 2026.

Reported by Stephen Odaibo, MD

Find the companies already in motion.

Customize signals around your market, buyers, competitors, and investment thesis.

© 2026 SeedOpsCompany intelligence.

SeedOps.